Novavax NVAX recorded a loss of 19 cents per share in the third quarter of 2026, narrower than the Zacks Consensus Estimate ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended ...

Novavax (NASDAQ:NVAX) raised its 2026 revenue framework after partner Sanofi began a late-stage trial of a combination ...

Sanofi milestones lifted revenue guidance to $400M, but profitability timing now depends on partner execution.

Gaithersburg-based Novavax reported a sharply narrower third-quarter loss, secured a $125 million milestone payment and outlined plans to extend its... Read More ...

In vitro studies, undertaken by two leading microbiology centers, confirm RHB-204's killing capability on Mycobacterium avium ...

Nearly $11 million grant supports study of gut bacteria St. Louis American staff Antibiotics can treat an infection while also wiping out helpful gut bacteria, allowing harmful bacteria to multiply.

Cover story: The Liggins Institute's findings have translated into clinical practices that have saved hundreds of thousands ...

Regina Barzilay, MIT's School of Engineering Distinguished Professor of AI and Health, and James Collins, MIT's Termeer Professor of Medical ...

Stay updated with Business News This Week – your source for the latest business news weekly, market updates, and top business ...

Novavax Q3 2026 revenue was $68 million and net loss narrowed to $31 million, while adjusted 2026 revenue guidance rose to a ...

We have been covering various features accommodated in Windows 11/10 to help you understand them better, before getting started because well begun is half done! One new feature that Microsoft has ...